KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Edwards Lifesciences (EW) Assets Average (2016 - 2025)

Historic Assets Average for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $13.4 billion.

  • Edwards Lifesciences' Assets Average rose 1599.62% to $13.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $13.4 billion, marking a year-over-year increase of 1599.62%. This contributed to the annual value of $11.2 billion for FY2024, which is 2697.6% up from last year.
  • Edwards Lifesciences' Assets Average amounted to $13.4 billion in Q3 2025, which was up 1599.62% from $13.3 billion recorded in Q2 2025.
  • Edwards Lifesciences' Assets Average's 5-year high stood at $13.4 billion during Q3 2025, with a 5-year trough of $7.2 billion in Q1 2021.
  • Its 5-year average for Assets Average is $9.7 billion, with a median of $8.8 billion in 2023.
  • Per our database at Business Quant, Edwards Lifesciences' Assets Average grew by 12.53% in 2023 and then surged by 3892.66% in 2024.
  • Over the past 5 years, Edwards Lifesciences' Assets Average (Quarter) stood at $8.3 billion in 2021, then increased by 1.61% to $8.5 billion in 2022, then increased by 10.65% to $9.4 billion in 2023, then surged by 38.93% to $13.0 billion in 2024, then rose by 2.82% to $13.4 billion in 2025.
  • Its Assets Average was $13.4 billion in Q3 2025, compared to $13.3 billion in Q2 2025 and $13.0 billion in Q1 2025.